Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of ZNF397 mRNA | CTD | PMID:30165855 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Zfp397 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Zfp397 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Zfp397 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ZFP397 mRNA | CTD | PMID:21570461 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZNF397 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ZNF397 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ZNF397 mRNA | CTD | PMID:28628672 | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of ZNF397 mRNA | CTD | PMID:33167477 | belinostat | increases expression | EXP | | 6480464 | belinostat results in increased expression of ZNF397 mRNA | CTD | PMID:27188386 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of ZNF397 mRNA | CTD | PMID:20064835 | bisphenol A | decreases expression | ISO | Zfp397 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of ZFP397 mRNA | CTD | PMID:30816183 | bisphenol A | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZNF397 mRNA | CTD | PMID:28628672 | Butylparaben | increases expression | EXP | | 6480464 | butylparaben results in increased expression of ZNF397 mRNA | CTD | PMID:17121429 | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ZNF397 gene] | CTD | PMID:28238834 | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of ZNF397 mRNA | CTD | PMID:19549813 | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZNF397 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ZNF397 mRNA | CTD | PMID:28628672 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of ZNF397 mRNA | CTD | PMID:29803840 | folic acid | decreases expression | ISO | Zfp397 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of ZFP397 mRNA | CTD | PMID:25629700 | gentamycin | decreases expression | ISO | Zfp397 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of ZFP397 mRNA | CTD | PMID:33387578 | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZNF397 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ZNF397 mRNA | CTD | PMID:28628672 | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of ZNF397 mRNA | CTD | PMID:28001369 | methylparaben | increases expression | EXP | | 6480464 | methylparaben results in increased expression of ZNF397 mRNA | CTD | PMID:17121429 | miconazole | decreases expression | ISO | Zfp397 (Mus musculus) | 6480464 | Miconazole results in decreased expression of ZFP397 mRNA | CTD | PMID:27462272 | PCB138 | multiple interactions | ISO | Zfp397 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | phenylmercury acetate | decreases expression | EXP | | 6480464 | Phenylmercuric Acetate results in decreased expression of ZNF397 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF397 mRNA | CTD | PMID:27188386 | potassium chloride | multiple interactions | EXP | | 6480464 | [Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of ZNF397 mRNA | CTD | PMID:29691375 | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of ZNF397 mRNA | CTD | PMID:23557933 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silver atom | affects expression | ISO | Zfp397 (Mus musculus) | 6480464 | Silver affects the expression of ZFP397 mRNA | CTD | PMID:27131904 | silver(0) | affects expression | ISO | Zfp397 (Mus musculus) | 6480464 | Silver affects the expression of ZFP397 mRNA | CTD | PMID:27131904 | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of ZNF397 mRNA | CTD | PMID:24935251 | trichostatin A | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF397 mRNA | CTD | PMID:27188386 | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of ZNF397 mRNA | CTD | PMID:24935251 and PMID:26272509 | troglitazone | decreases expression | ISO | Zfp397 (Mus musculus) | 6480464 | troglitazone results in decreased expression of ZNF397 mRNA | CTD | PMID:28973697 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of ZNF397 mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF397 mRNA | CTD | PMID:27188386 | |